Moderna explores outside financing for vaccine trials, shares dip
Go back to Moderna explores outside financing for vaccine trials, shares dip| THE BLACKSTONE GROUP L.P (NYSE: BX) | Delayed: 137.13 +3.68 (2.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $133.45 | 52 Week High | $32.07 | |||
| Open | $135.10 | 52 Week Low | $22.31 | |||
| Day High | $138.50 | P/E | 121.35 | |||
| Day Low | $134.62 | EPS | $1.13 | |||
| Volume | 4,069,786 | |||||
| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 59.17 +5.31 (9.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $53.86 | 52 Week High | $0.52 | |||
| Open | $54.79 | 52 Week Low | $0.08 | |||
| Day High | $59.42 | P/E | N/A | |||
| Day Low | $54.62 | EPS | $-3.80 | |||
| Volume | 6,818,563 | |||||
